A Simulation Study of the Effects of Number and Location of MitraClips on Mitral Regurgitation
- PMID: 38939090
- PMCID: PMC11198285
- DOI: 10.1016/j.jacadv.2022.100015
A Simulation Study of the Effects of Number and Location of MitraClips on Mitral Regurgitation
Abstract
Background: MitraClip (MC) is a device that is implanted on the mitral valve (MV) percutaneously to treat severe mitral regurgitation (MR). It is common practice to place the MCs at the site of the most significant MR jets identified by echocardiography.
Objectives: We used computational modeling to examine changes in MR after MC placement.
Methods: Echocardiographic images from 29 patients with MR were analyzed to reconstruct geometries for finite element simulations and created fluid structure interaction models of the MV with deformable hyperelastic material, the left ventricle as the surrounding geometry, and blood flow. Blood flow was modelled with smoothed particle hydrodynamics. The number of blood particles on the atrial side of MV was used to estimate MR. MC placement was based on the MR jets (jet-based strategy using primary and secondary jets) and simulation models using various MCs locations.
Results: Computational modelling was able to quantitate reductions in MR after MC placement. Reduction in MR was related to the number of MCs used: 42% reduction with 1 MC, 62% with 2 MCs, and 88% with 3 MCs. Using 2 MCs did not always result in an MR reduction greater than with a single MC. In 31% (9 of 29) of patients, the jet-based strategy did not lead to maximum MR reduction. The majority of patients (89%) who did not have maximal MR reduction with the MC placement using the jet-based strategy, had wide jets, and/or had multiple jets.
Conclusions: Subject-specific simulation models may be helpful to identify optimal locations for MC placement in patients with MR.
Keywords: MitraClip; intervention; mitral regurgitation; mitral valve; simulation.
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Conflict of interest statement
This work was supported in part by the 10.13039/100006370SBIR Grant Number R43 HL145896. Dr Dabiri is an employee of 3DT Holdings LLC. Dr Mahadevan is Principal Investigator for clinical research with Abbott, Edwards Life Sciences, and GORE. Dr Guccione has served as a consultant for Dassault Systèmes Simulia Corporation. Dr Kassab has reported that he has no relationships relevant to the contents of this paper to disclose.
Figures








References
-
- Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–1243. - PubMed
-
- Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121:948–954. - PubMed
-
- St. Goar F.G., Fann J.I., Komtebedde J., et al. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation. 2003;108(16):1990–1993. - PubMed
-
- Alegria-Barrero E., Chan P.H., Foin N., et al. Concept of the central clip: when to use one or two MitraClips®. EuroIntervention. 2014;9(10):1217–1224. - PubMed
LinkOut - more resources
Full Text Sources